Hypothalamic expression of neuropeptide-Y in the New Zealand obese mouse

International Journal of Obesity

Volumn 22, Issue 12, 1998, Pages 1172-1177

  Rizk, N M ^a   Liu, Li Sen ^b   Eckel, Jürgen ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Hypothalamus and obesity; Leptin receptor; Neuropeptide Y; New Zealand obese (NZO) mouse

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPOTHALAMUS; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA;

EID: 0031794333     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800742     Document Type: Article

References (29)

1. Sahu A, Karla P, Kalyra SP. Food deprivation and ingestion induce reciprocal changes in neuropeptide-Y concentrations in the paraventricular nucleus. Peptides 1988; 9: 83-86.
2. White JD, Kershaw M. Increased hypothalamic neuropeptide-Y expression following food deprivation. Mol Cell Neurosci 1989; 1: 41-48.
3. Morley J, Hernandez EN, Flood JE. Neuropeptide-Y increases food intake in mice. Am J Physiol 1987; 253: R516-R522.
4. Clark JT, Kalra PS, Kalra SP. Neuropeptide-Y stimulates feeding but inhibits sexual behaviour in rats. Endocrinology 1985; 117: 2435-2442.
5. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse ob gene and its human homologue. Nature 1994; 372: 425-432.
6. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallon RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
7. Cusin I, Rohner-Jeanrenaud F, Stricker-Krongard A, Jeanrenaud B. The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Diabetes 1996; 45: 1446-1450.
8. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 9: 491-495.
9. Steiner RA. Editorial: Lords and Ladies leapin' on leptin. Endocrinology 1996; 137: 4533-4535
10. Woods SC, Lotter EC, McKay LD, Porte D Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and bodyweight of baboons. Nature 1979; 282: 503-505.
11. Woods SC, Stein LJ, McKay LD, Porte D Jr. Suppression of food intake by intravenous nutrients and insulin in the baboon. Am J Physiol 1984; 247: R393-R401.
12. Schwärtz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SR, Baskin DG, Woods SC, Figlewicz DP, Porte D Jr. Inhibition of hypothalamic neuropeptide-Y gene expression by insulin. Endocrinology 1992; 130: 3608-3616.
13. Schwärtz MW, Dallman MF, Woods SC. Hypothalamic response to starvation: implication for the study of wasting disorders. Am J Physiol 1995; 269: 949-957.
14. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. The ob gene and insulin: a relationship leading to clues to the understanding of obesity. Diabetes 1995; 44: 1467-1470.
15. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck Jr PR, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M. The role of neuropeptide-Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-532.
16. Hamann A, Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 1996; 104: 293-300
17. Herberg L, Coleman DL. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 1977; 26: 59-99.
18. Igel M, Becker W, Herberg L, Joost H-G. Hyperleptinemia, leptin resistance and polymorphic leptin receptor in the New Zealand obese mouse. Endocrinology 1997; 138: 4234-4239.
19. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-635.
20. Bchini O, Huijsduijnen HV, Rohner-Jeanrenaud F, Jeanrenaud B. Hypothalamic neuropeptide-Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats; potential regulation by corticotropin-releasing factor. J Neuroendocrinol 1993; 5: 381-386.
21. Wilding JP, Gilbey SG, Bailey CJ, Batt RAL, Williams G, Ghatei MA, Bloom SR. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 1993; 132: 1939-1944.
22. Igel M, Kainulainen H, Brauers A, Becker W, Herberg L, Joost H-G. Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese (db/db mice, fa/fa rats) rodents. Diabetalogia 1996; 39: 758-765.
23. Sanacaro G, Kershaw M, Finkelstein IA, White JD. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 1990; 127: 730-737.
24. Leibowitz SF. Brain neuropeptide-Y: an integrator of endocrine, metabolic and behavioural processes. Brain Res Bull 1991; 27: 333-337.
25. Stauffacher W, Lambert AE, Vecchio D, Renold AE. Measurements of insulin activities in pancreas and serum of mice with spontaneous ('obese' and 'New Zealand obese') and induced (goldthioglucose) obesity and hyperglycemia, with considerations on the pathogenesis of the spontaneous syndrome. Diabetologia 1967; 3: 230-237.
26. Considine RV, Considine FL, Williams CJ, Hyde TM, Caro JF. The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996; 45: 992-994.
27. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161.
28. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996; 93: 6231-6235.
29. Schwartz MW, Marks JL, Sipols AJ, Baskin DG, Woods SC, Kahn SE, Poste D Jr. Central insulin administration reduces neuropeptide-Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 1991; 128: 2645-2647.